论文部分内容阅读
乙型脑炎病毒（ＪＥＶ）ＳＡ１４－１４－２株减毒活疫苗由中国研制，为评价其在中国以外地区的使用效果，作者对韩国儿童初次和加强免疫该疫苗后的免疫应答进行了研究。研究对象为乙型脑炎低流行区的１～３岁儿童，对８４名儿童接种由中国成都生物制品研究所生产的ＳＡ１４－
The attenuated live vaccine of Japanese encephalitis virus (JEV) strain SA14-14-2 was developed in China. In order to evaluate the efficacy of JEV vaccine in areas outside of China, the author studied the immune responses of Korean children after initial and intensive immunization of the vaccine . The study was conducted in children aged 1-3 years with low endemic area of Japanese encephalitis and 84 children were vaccinated with the SA14-